
Absci Corp (ABSI) Stock Forecast & Price Target
Absci Corp (ABSI) Analyst Ratings
Bulls say
Absci is primed to disrupt the hair loss treatment market with its novel biologic, ABS-201, which utilizes advanced AI and synthetic biology to target the PRLR pathway with an extended half-life. The company has a comprehensive understanding of the mechanisms involved in hair growth and have shown promising preclinical and clinical results, with a potentially superior product profile compared to existing hair loss treatments. This, combined with a large and growing market, suggests strong potential for Absci's success and future growth.
Bears say
Absci is heavily reliant on external funding as it expands its discovery platform and takes its candidates through clinical trials, which may be difficult to obtain on favorable terms. Its existing partnerships may not reach fruition or continue to contribute significant revenues, and there are potential safety and competition risks surrounding ABS-201's effectiveness in promoting hair growth.
This aggregate rating is based on analysts' research of Absci Corp and is not a guaranteed prediction by Public.com or investment advice.
Absci Corp (ABSI) Analyst Forecast & Price Prediction
Start investing in Absci Corp (ABSI)
Order type
Buy in
Order amount
Est. shares
0 shares